Emergence Partners is pleased to announce that it served as the exclusive financial advisor to Omerin SAS, the world leader in the manufacture of special cables and wires on its recently announced acquisition of 100% stake in Prince Medical SA, a French medical devices manufacturer.
The transaction, closed on November 25th of 2019, has affirmed Omerin SAS’ strategy of reinforcing its healthcare division. Multiple synergies are expected to be achieved within the group healthcare division following this acquisition.
“The Emergence team worked closely with us through each step of the transaction process to identify and select the right acquisition target and to ultimately achieve an optimal transaction. We benefitted greatly from the team’s market expertise and transactional experience.” said Xavier Omerin, Omerin Group chairman and CEO.
About Omerin Group
Founded in 1959, Omerin group revenues amount to EUR 230m and has 1700 employees across15 production sites established in France, in Tunisia, in Spain and in the United States. It is recognized to be the French, European and global leader in 4 different categories. Omerin operates in four business units that are Electrical wires & cables and braided sleevings, Flexible heating elements, Sanitary and HVAC hoses and medical devices and primary pharmaceutical packaging.
About Prince Medical
Prince Medical manufactures and distributes since 1993 single use medical devices in the fields of gynecology, gastro-enterology and urology. It has two production sites employing 465 people and located in France and in Tunisia and has total sales of EUR 15m. The company’s processes include the injection and the extrusion of plastic materials and the packaging and the sterilization of medical devices. It is ISO 13485 certified.